OPKO Health
OPK
NZ$2.14
Share price
-3.01%
Change (1 day)
5.30%
Change (1 year)
Categories
OPKO Health (OPK) - P/B ratio
P/B ratio as of June 2025 : 0.7800
According to OPKO Health
's latest financial reports the company has a price-to-book ratio of 1.48394.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
OPKO Health - P/B ratio (from 2001 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 0.7292 | -13.21% |
| 2023-12-31 | 0.8403 | 35.86% |
| 2022-12-31 | 0.6185 | -68.2% |
| 2021-12-31 | 1.94 | 22.84% |
| 2020-12-31 | 1.58 | 159.64% |
| 2019-12-31 | 0.6098 | -38.11% |
| 2018-12-31 | 0.9852 | -33.73% |
| 2017-12-31 | 1.49 | -40.02% |
| 2016-12-31 | 2.48 | -10.41% |
| 2015-12-31 | 2.77 | -46.44% |
| 2014-12-31 | 5.17 | 29.52% |
| 2013-12-31 | 3.99 | -44.83% |
| 2012-12-31 | 7.23 | -5.82% |
| 2011-12-31 | 7.68 | -81.12% |
| 2010-12-31 | 40.7 | 176.69% |
| 2009-12-31 | 14.7 | -98.36% |
| 2008-12-31 | 897 | 2861.26% |
| 2007-12-31 | 30.3 | -95.6% |
| 2006-12-31 | 688 | 86593.57% |
| 2005-12-31 | 0.7933 | 41.35% |
| 2004-12-31 | 0.5612 | -59.04% |
| 2003-12-31 | 1.37 | 288.78% |
| 2002-12-31 | 0.3524 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.69 | 501.82% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.69 | 501.41% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 1.87 | 139.69% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 3.09 | 296.15% | 🇮🇱 Israel |
 Alnylam Pharmaceuticals
ALNY | 349 | 44,607.46% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.51 | 606.29% | 🇺🇸 USA |
 LabCorp LH | 2.61 | 234.58% | 🇺🇸 USA |
 Ardelyx ARDX | 5.83 | 647.53% | 🇺🇸 USA |